Development Engineering Centre of Liaoning Province

The Liaoning Provincial Institute of Drug Research (LPIDR) is a prominent state-owned pharmaceutical research and development organization based in Shenyang, China. Established in 1958, the institute hosts the Liaoning Province Drug Research and Development Engineering Technology Center and serves as a central hub for pharmaceutical innovation in Northeast China. LPIDR specializes in the discovery and development of small molecule drugs, modernized traditional Chinese medicines (TCM), and advanced drug delivery systems, with a particular focus on oncology, cardiovascular, and metabolic therapeutic areas. The institute provides a comprehensive range of contract research services, including CMC development, pre-clinical pharmacological evaluation, and pilot-scale manufacturing. Over its long history, LPIDR has successfully developed numerous products that have transitioned to the commercial market through strategic partnerships with major pharmaceutical companies.